Contemporary Clinical Trials Communications

Contemporary Clinical Trials Communications
影响因子:
1.4
ISSN:
print: 2451-8654
研究领域:
Pharmacology, Toxicology and Pharmaceutics-Pharmacology
自引率:
6.70%
Gold OA文章占比:
95.19%
原创研究文献占比:
96.84%
SCI收录类型:
Emerging Sources Citation Index (ESCI) || Scopus (CiteScore) || Directory of Open Access Journals (DOAJ)
期刊介绍英文:
Contemporary Clinical Trials Communications is an international peer reviewed open access journal that publishes articles pertaining to all aspects of clinical trials, including, but not limited to, design, conduct, analysis, regulation and ethics. Manuscripts submitted should appeal to a readership drawn from a wide range of disciplines including medicine, life science, pharmaceutical science, biostatistics, epidemiology, computer science, management science, behavioral science, and bioethics. Contemporary Clinical Trials Communications is unique in that it is outside the confines of disease specifications, and it strives to increase the transparency of medical research and reduce publication bias by publishing scientifically valid original research findings irrespective of their perceived importance, significance or impact. Both randomized and non-randomized trials are within the scope of the Journal. Some common topics include trial design rationale and methods, operational methodologies and challenges, and positive and negative trial results. In addition to original research, the Journal also welcomes other types of communications including, but are not limited to, methodology reviews, perspectives and discussions. Through timely dissemination of advances in clinical trials, the goal of Contemporary Clinical Trials Communications is to serve as a platform to enhance the communication and collaboration within the global clinical trials community that ultimately advances this field of research for the benefit of patients.
CiteScore:
CiteScoreSJRSNIPCiteScore排名
2.70.6360.657
学科
排名
百分位
大类:Medicine
小类:General Medicine
199 / 636
68%
大类:Pharmacology, Toxicology and Pharmaceutics
小类:Pharmacology
217 / 313
30%
发文信息
WOS期刊分区
学科分类
Q4MEDICINE, RESEARCH & EXPERIMENTAL
历年影响因子
2022年1.5000
2023年1.4000
历年发表
2013年0
2015年9
2016年70
2017年121
2018年109
2019年187
2020年200
2021年176
2022年146
投稿信息
出版语言:
English
出版国家(地区):
United States
接受率:
58%
初审时长:
18 weeks
审稿时长:
20 weeks
发表时长:
2 weeks
论文处理费:
$1950
出版商:
Elsevier

Contemporary Clinical Trials Communications - 最新文献

A Bayesian adaptive feasibility design for rare diseases

Pub Date : 2024-11-09 DOI: 10.1016/j.conctc.2024.101392 Maureen M. Churipuy , Shirin Golchi , Marie Hudson , Sabrina Hoa

A protocol for modifying progesterone to increase postpartum cigarette smoking abstinence and reduce secondhand smoke exposure in infants

Pub Date : 2024-11-06 DOI: 10.1016/j.conctc.2024.101389 Nermine Abdelwahab , Alicia Allen , Katherine Harrison , Ashley Petersen , Sharon Allen

An automated platform trial framework for A/B testing

Pub Date : 2024-11-04 DOI: 10.1016/j.conctc.2024.101388 Wenru Zhou , Miranda Kroehl , Maxene Meier , Alexander Kaizer
查看全部
免责声明:
本页显示期刊或杂志信息,仅供参考学习,不是任何期刊杂志官网,不涉及出版事务,特此申明。如需出版一切事务需要用户自己向出版商联系核实。若本页展示内容有任何问题,请联系我们,邮箱:info@booksci.cn,我们会认真核实处理。
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信